Ubiquitylation of Cyclin E Requires the Sequential Function of SCF Complexes Containing Distinct hCdc4 Isoforms

Molecular Cell

Volumn 23, Issue 1, 2006, Pages 37-48

  van Drogen, Frank ^a   Sangfelt, Olle ^a,b   Malyukova, Aljona ^b   Matskova, Ludmila ^b   Yeh, Elizabeth ^c   Means, Anthony R ^c   Reed, Steven I ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CELLCYLCE; PROTEINS

Indexed keywords

CELL CYCLE PROTEIN; CELL DIVISION CYCLE PROTEIN 4ALPHA; CYCLIN DEPENDENT KINASE 2; CYCLIN E; F BOX PROTEIN; ISOMERASE PIN1; ISOPROTEIN; PROLINE; SKP1 CUL1 F BOX PROTEIN UBIQUITIN LIGASE; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; ISOMERIZATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA SPLICING; UBIQUITINATION;

BINDING SITES; CELL CYCLE PROTEINS; CELL LINE; CYCLIN E; F-BOX PROTEINS; GENE SILENCING; HUMANS; ISOENZYMES; MODELS, BIOLOGICAL; MUTATION; PEPTIDYLPROLYL ISOMERASE; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 33745508920     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.05.020     Document Type: Article

References (49)

1. Ang X.L., and Wade Harper J. SCF-mediated protein degradation and cell cycle control. Oncogene 24 (2005) 2860-2870
2. Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J.W., and Elledge S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86 (1996) 263-274
3. Bortner D.M., and Rosenberg M.P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell. Biol. 17 (1997) 453-459
4. Brown N.R., Noble M.E., Endicott J.A., and Johnson L.N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1 (1999) 438-443
5. Calhoun E.S., Jones J.B., Ashfaq R., Adsay V., Baker S.J., Valentine V., Hempen P.M., Hilgers W., Yeo C.J., Hruban R.H., and Kern S.E. BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. Am. J. Pathol. 163 (2003) 1255-1260
6. Clurman B.E., Sheaff R.J., Thress K., Groudine M., and Roberts J.M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10 (1996) 1979-1990
7. Donnellan R., and Chetty R. Cyclin E in human cancers. FASEB J. 13 (1999) 773-780
8. Dulic V., Lees E., and Reed S.I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257 (1992) 1958-1961
9. Ekholm S.V., and Reed S.I. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12 (2000) 676-684
10. Ekholm S.V., Zickert P., Reed S.I., and Zetterberg A. Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol. Cell. Biol. 21 (2001) 3256-3265
11. Ekholm-Reed S., Spruck C.H., Sangfelt O., van Drogen F., Mueller-Holzner E., Widschwendter M., Zetterberg A., and Reed S.I. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Cancer Res. 64 (2004) 795-800
12. Gupta-Rossi N., Le Bail O., Gonen H., Brou C., Logeat F., Six E., Ciechanover A., and Israel A. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem. 276 (2001) 34371-34378
13. Hennig L., Christner C., Kipping M., Schelbert B., Rucknagel K.P., Grabley S., Kullertz G., and Fischer G. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37 (1998) 5953-5960
14. Hershko A. Ubiquitin: roles in protein modification and breakdown. Cell 34 (1983) 11-12
15. Joseph J.D., Yeh E.S., Swenson K.I., Means A.R., and Winkler. The peptidyl-prolyl isomerase Pin1. Prog. Cell Cycle Res. 5 (2003) 477-487
16. Fbw7 ubiquitin ligase. Science 294 (2001) 173-177
17. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S., Nishimoto T., Morgan D.O., Franza B.R., and Roberts J.M. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257 (1992) 1689-1694
18. Kominami K., Ochotorena I., and Toda T. Two F-box/WD-repeat proteins Pop1 and Pop2 form hetero- and homo-complexes together with cullin-1 in the fission yeast SCF (Skp1-Cullin-1-F-box) ubiquitin ligase. Genes Cells 3 (1998) 721-735
19. Lees E., Faha B., Dulic V., Reed S.I., and Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6 (1992) 1874-1885
20. Lu K.P. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 29 (2004) 200-209
21. Lu K.P., Liou Y.C., and Zhou X.Z. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 12 (2002) 164-172
22. Lu P.J., Zhou X.Z., Shen M., and Lu K.P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283 (1999) 1325-1328
23. Mantovani F., Piazza S., Gostissa M., Strano S., Zacchi P., Mantovani R., Blandino G., and Del Sal G. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 14 (2004) 625-636
24. McVey D., Brizuela L., Mohr I., Marshak D.R., Gluzman Y., and Beach D. Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication. Nature 341 (1989) 503-507
25. Moberg K.H., Bell D.W., Wahrer D.C., Haber D.A., and Hariharan I.K. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413 (2001) 311-316
26. Nash P., Tang X., Orlicky S., Chen Q., Gertler F.B., Mendenhall M.D., Sicheri F., Pawson T., and Tyers M. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414 (2001) 514-521
27. Ohtsubo M., and Roberts J.M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259 (1993) 1908-1912
28. Cdc4 ubiquitin ligase. Cell 112 (2003) 243-256
29. Rajagopalan H., Jallepalli P.V., Rago C., Velculescu V.E., Kinzler K.W., Vogelstein B., and Lengauer C. Inactivation of hCDC4 can cause chromosomal instability. Nature 428 (2004) 77-81
30. Reed S.I. Cyclin E: in mid-cycle. Biochim. Biophys. Acta 1287 (1996) 151-153
31. Resnitzky D., Gossen M., Bujard H., and Reed S.I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14 (1994) 1669-1679
32. Sandhu C., and Slingerland J. Deregulation of the cell cycle in cancer. Cancer Detect. Prev. 24 (2000) 107-118
33. Sauer K., and Lehner C.F. The role of cyclin E in the regulation of entry into S phase. Prog. Cell Cycle Res. 1 (1995) 125-139
34. Schraml P., Bucher C., Bissig H., Nocito A., Haas P., Wilber K., Seelig S., Kononen J., Mihatsch M.J., Dirnhofer S., and Sauter G. Cyclin E overexpression and amplification in human tumours. J. Pathol. 200 (2003) 375-382
35. Spruck C.H., Won K.A., and Reed S.I. Deregulated cyclin E induces chromosome instability. Nature 401 (1999) 297-300
36. Spruck C.H., Strohmaier H., Sangfelt O., Muller H.M., Hubalek M., Muller-Holzner E., Marth C., Widschwendter M., and Reed S.I. hCDC4 gene mutations in endometrial cancer. Cancer Res. 62 (2002) 4535-4539
37. Strohmaier H., Spruck C.H., Kaiser P., Won K.A., Sangfelt O., and Reed S.I. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413 (2001) 316-322
38. van der Voorn L., and Ploegh H.L. The WD-40 repeat. FEBS Lett. 307 (1992) 131-134
39. Wei W., Jin J., Schlisio S., Harper J.W., and Kaelin Jr. W.G. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8 (2005) 25-33
40. Weiwad M., Kullertz G., Schutkowski M., and Fischer G. Evidence that the substrate backbone conformation is critical to phosphorylation by p42 MAP kinase. FEBS Lett. 478 (2000) 39-42
41. Welcker M., Singer J., Loeb K.R., Grim J., Bloecher A., Gurien-West M., Clurman B.E., and Roberts J.M. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 12 (2003) 381-392
42. Welcker M., Orian A., Jin J., Grim J.A., Harper J.W., Eisenman R.N., and Clurman B.E. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. USA 101 (2004) 9085-9090
43. Winkler K.E., Swenson K.I., Kornbluth S., and Means A.R. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 287 (2000) 1644-1647
44. Wolf D.A., McKeon F., and Jackson P.K. F-box/WD-repeat proteins pop1p and Sud1p/Pop2p form complexes that bind and direct the proteolysis of cdc18p. Curr. Biol. 9 (1999) 373-376
45. Won K.A., and Reed S.I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15 (1996) 4182-4193
46. Yada M., Hatakeyama S., Kamura T., Nishiyama M., Tsunematsu R., Imaki H., Ishida N., Okumura F., Nakayama K., and Nakayama K.I. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23 (2004) 2116-2125
47. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278 (1997) 1957-1960
48. Yeh E., Cunningham M., Arnold H., Chasse D., Monteith T., Ivaldi G., Hahn W.C., Stukenberg P.T., Shenolikar S., Uchida T., et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6 (2004) 308-318
49. Yeh E.S., Lew B.O., and Means A.R. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J. Biol. Chem. 281 (2006) 241-251